论文部分内容阅读
血清中可溶性白介素-2受体（sIL－2R）是活化T细胞膜白介素-2受体（mIL－2R）的α链成份，作为一种新的免疫功能评价指标，被广泛应用于临床免疫学研究。我们选择急、慢性白血病及恶性淋巴瘤作为观察对象，动态观察患者血清sIL－2R水平的变化，旨在了解其变化特点和临床价值。1
Serum soluble interleukin-2 receptor (sIL-2R) is the alpha-chain component of the activated T-cell interleukin-2 receptor (mIL-2R). As a new immune function evaluation index, it is widely used in clinical immunology research. . We chose acute and chronic leukemia and malignant lymphoma as observation objects to dynamically observe changes in serum sIL-2R levels in patients to understand its changing characteristics and clinical value. 1